Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirapazamine and Cisplatin in Recurrent Ovarian or Primary Peritoneal Cancer
NCT00020696Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Jun 2001
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of tirapazamine in ovarian cancer, primary peritoneal cancer (PPC), sponsored by GOG Foundation. Started Jun 2001; status: completed.
02
Drugs
tirapazamine
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00020696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020696.